13F HOLDINGS REPORT
OUP Management Co., LLC
Quarter ended Q3 2023 · Filed August 7, 2023 · Accession 0000950123-23-006774
Total Value
$58.6M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Centessa Pharmaceuticals plc | CNTA | 2,937,615 | $18.2M | 31.01% |
| 2 | DICE Therapeutics Inc. | 23345J104 | 268,346 | $12.5M | 21.26% |
| 3 | Aerovate Therapeutics Inc. | 008064107 | 603,762 | $10.4M | 17.66% |
| 4 | Cyteir Therapeutics, Inc. | 23284P103 | 2,459,572 | $6.4M | 10.91% |
| 5 | PMV Pharmaceuticals, Inc. | PMVP | 989,232 | $6.2M | 10.56% |
| 6 | Vor Biopharma Inc. | VOR | 374,714 | $1.2M | 1.97% |
| 7 | Graphite Bio | 38870X104 | 406,308 | $1.1M | 1.80% |
| 8 | Selecta Biosciences, Inc. | 816212104 | 862,543 | $966,048 | 1.65% |
| 9 | eFFECTOR Therapeutics, Inc. | 28202V108 | 1,025,697 | $851,534 | 1.45% |
| 10 | Precision BioSciences, Inc. | DTIL | 1,123,913 | $591,178 | 1.01% |
| 11 | Spero Therapeutics, Inc. | SPRO | 249,070 | $361,152 | 0.62% |
| 12 | Homology Medicines, Inc. | 438083107 | 64,000 | $56,640 | 0.10% |